Table 1.
Baseline characteristics of study population.
Fig 1.
Overall (A) and cancer-specific survival (B) of young (group 1) and elderly (group 2) patients with TNBC.
n, number of patients; O, observed events.
Table 2.
Outcome-related factors in triple-negative breast cancer by multivariate analysis.
Fig 2.
Cancer-specific survival of young (group 1) and elderly (group 2) patients with TNBC stratified by TNM stages and tumor grade.
(A) Patients with stage I, grade I-II disease (n = 983). (B) Patients with stage I, grade III-IV disease (n = 2445). (C) Patients with stage II, grade I-II disease (n = 589). (D) Patients with stage II, grade III-IV disease (n = 3681). (E) Patients with stage III, grade I-II disease (n = 214). (F) Patients with stage III, grade III-IV disease (n = 1372).
Fig 3.
Overall survival of young (group 1) and elderly (group 2) patients with TNBC stratified by TNM stages and tumor grade.
(A) Patients with stage I, grade I-II disease (n = 983). (B) Patients with stage I, grade III-IV disease (n = 2445). (C) Patients with stage II, grade I-II disease (n = 589). (D) Patients with stage II, grade III-IV disease (n = 3681). (E) Patients with stage III, grade I-II disease (n = 214). (F) Patients with stage III, grade III-IV disease (n = 1372).
Table 3.
Patterns of care in young (<70 years) and old-aged (≥70 years) patients with triple-negative breast cancer by TNM stage.
Table 4.
Use of radiotherapy in patients for whom radiation following breast-conserving surgery or mastectomy should be indicated.
Table 5.
Use of radiotherapy in patients for whom radiation following breast-conserving surgery or mastectomya should be indicated stratified by TNM stage.